Study identifies potential new drug for Parkinson’s-related cognitive decline, dementia

BIO5 members Lalitha Madhavan and Robin Polt are part of a group of researchers who published a study finding that a tiny protein called PNA5 appears to have a protective effect on brain cells, which could lead to treatments for the cognitive symptoms of Parkinson’s disease and related disorders.